Abiopharma

🔍 Tighe Mary Ann (Director)

Company: Howard Hughes Holdings Inc. (HHH)

Report Date: 2026-06-19

Detailed Transactions and Holdings:

• Acquired 3,290 shares of Common stock, $0.01 par value (Direct)
  Date: 2026-06-19 | Code: A | equity_swap_involved: 0 | shares_owned_after: 37,371.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common stock, $0.01 par value (Direct)
  Date: 2026-06-19 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 13,495.00 | Footnotes: F2

Footnotes:

• F1: Represents restricted stock granted to non-employee directors pursuant to the Issuer's 2025 Equity Incentive Plan. The shares vest on the earlier of the 2027 annual meeting of stockholders of Howard Hughes Holdings Inc. or June 1, 2027.
• F2: Represents shares owned by the reporting person's husband who shares the reporting person's household. The reporting person may be deemed to be the beneficial owner of the shares of common stock of Howard Hughes Holdings Inc. owned by the reporting person's husband.